Nov 4 2009
Emerson Resources, Inc., a premier pharmaceutical solutions company, today announced that it has formed a strategic partnership with Bio Research, a contract research organization that specializes in the agrichemical and related industries, to further extend its business development capabilities. The exclusive partnership leverages the expertise of industry veteran Robert Westbrook, CEO of Bio Research, who is spearheading Emerson Resources' intensified business development and sales efforts.
Through the partnership, Emerson Resources will work together with Bio Research to establish an even greater footprint in the pharmaceutical and biotech sectors. Currently, Emerson Resources serves hundreds of global organizations including branded, generic and OTC pharmaceutical companies, virtual and emerging pharmaceutical research organizations, raw material suppliers, equipment manufacturers, and intellectual property attorneys.
"Our partnership with Bio Research will strengthen our position as the leader in value-added service, ingredients and expertise," said Adolfo Gomez, President of Emerson Resources. "Robert brings a strong combination of business development skills and diverse industry insight to Emerson and I am confident that he and his team will vastly expand our industry presence -- particularly on the West Coast, an area that is ripe with opportunity."
Emerson Resources selected Bio Research, based in Fresno, California, for its track record of delivering high-quality results, stellar management team and specific industry focus. Its subsidiary, Bio Research Services, represents select products and services related to clinical diagnostics, drug discovery, drug development, and agrichemicals.
As Emerson Resources' new dedicated business development executive, Mr. Westbrook -- who has more than 17 years of industry experience -- will focus on creating new sales channels and building client and industry relationships in support of the Company's strategic growth objectives.
Research examines antibiotic use during COVID-19 by age